MX4950E - Procedimiento para la preparacion de tioesteres de acido clavulanico - Google Patents

Procedimiento para la preparacion de tioesteres de acido clavulanico

Info

Publication number
MX4950E
MX4950E MX775395U MX539577U MX4950E MX 4950 E MX4950 E MX 4950E MX 775395 U MX775395 U MX 775395U MX 539577 U MX539577 U MX 539577U MX 4950 E MX4950 E MX 4950E
Authority
MX
Mexico
Prior art keywords
procedure
preparation
clavulanic acid
acid thioesters
thioesters
Prior art date
Application number
MX775395U
Other languages
English (en)
Inventor
Roger John Ponsford
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB3892/76A external-priority patent/GB1574906A/en
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of MX4950E publication Critical patent/MX4950E/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
MX775395U 1976-01-31 1977-01-28 Procedimiento para la preparacion de tioesteres de acido clavulanico MX4950E (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3892/76A GB1574906A (en) 1976-01-31 1976-01-31 Therapeutic compounds containing - lactams
GB1900276 1976-05-08

Publications (1)

Publication Number Publication Date
MX4950E true MX4950E (es) 1983-01-12

Family

ID=26238678

Family Applications (1)

Application Number Title Priority Date Filing Date
MX775395U MX4950E (es) 1976-01-31 1977-01-28 Procedimiento para la preparacion de tioesteres de acido clavulanico

Country Status (31)

Country Link
US (2) US4428958A (es)
JP (1) JPS5295689A (es)
AR (3) AR214306A1 (es)
AT (1) AT351675B (es)
AU (1) AU515736B2 (es)
BG (1) BG27751A3 (es)
CA (1) CA1089471A (es)
CH (2) CH637655A5 (es)
CS (1) CS196341B2 (es)
DD (1) DD128196A5 (es)
DE (1) DE2702954A1 (es)
DK (1) DK146940C (es)
ES (1) ES455404A1 (es)
FI (1) FI63581C (es)
FR (1) FR2339616A1 (es)
GR (1) GR62544B (es)
HK (1) HK69883A (es)
IE (1) IE44759B1 (es)
IL (1) IL51267A (es)
KE (1) KE3303A (es)
LU (1) LU76668A1 (es)
MX (1) MX4950E (es)
NL (1) NL7700892A (es)
NO (1) NO770279L (es)
NZ (1) NZ183117A (es)
PH (1) PH13924A (es)
PT (1) PT66071B (es)
RO (1) RO69712A (es)
SE (1) SE441359B (es)
SU (1) SU645583A3 (es)
YU (1) YU10777A (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582884A (en) * 1977-05-19 1981-01-14 Beecham Group Ltd Clavulanic acid derivatives their preparation and use
GB2004541B (en) * 1977-09-16 1982-05-12 Beecham Group Ltd Ethers of clavulanic acid a process for their preparation and pharmaceutical compositions containing them
EP0008899B1 (en) * 1978-09-05 1982-09-15 Beecham Group Plc Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them
DE3062168D1 (en) * 1979-04-21 1983-04-07 Beecham Group Plc Clavulanic acid derivatives, their preparation and use in pharmaceutical compositions
NZ193687A (en) * 1979-05-17 1982-12-21 Beecham Group Ltd Clavulanic acid derivatives and pharmaceutical compositions
DK330880A (da) * 1979-08-03 1981-02-04 Beecham Group Ltd Fremgangsmaade til fremstilling af clavulansyrederivater
EP0053893B1 (en) * 1980-12-09 1985-03-20 Beecham Group Plc Derivatives of clavulanic acid, their preparation and their use
NZ199200A (en) * 1980-12-23 1984-07-31 Beecham Group Ltd Clavulanic acid derivatives and pharmaceutical compositions
GB9518917D0 (en) * 1995-09-15 1995-11-15 Smithkline Beecham Plc Compounds
US5958462A (en) * 1997-05-23 1999-09-28 Mclean; Linsey Therapeutic bath salts and method of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4039673A (en) 1973-10-30 1977-08-02 Bayer Aktiengesellschaft Penicillins and cephalosporins and their production
US3983113A (en) 1975-08-15 1976-09-28 Syntex (U.S.A.) Inc. Cephalosporin type antibacterials

Also Published As

Publication number Publication date
FI63581C (fi) 1983-07-11
US4505894A (en) 1985-03-19
AR214306A1 (es) 1979-05-31
BG27751A3 (en) 1979-12-12
PH13924A (en) 1980-11-04
SU645583A3 (ru) 1979-01-30
AR216925A1 (es) 1980-02-15
AT351675B (de) 1979-08-10
NZ183117A (en) 1979-10-25
DK146940B (da) 1984-02-20
FR2339616A1 (fr) 1977-08-26
ATA53477A (de) 1979-01-15
NO770279L (no) 1977-08-02
HK69883A (en) 1983-12-23
GR62544B (en) 1979-05-07
DD128196A5 (de) 1977-11-02
CA1089471A (en) 1980-11-11
DE2702954A1 (de) 1977-08-04
LU76668A1 (es) 1977-06-28
CH637655A5 (de) 1983-08-15
PT66071A (en) 1977-02-01
JPS5295689A (en) 1977-08-11
FR2339616B1 (es) 1980-04-11
IL51267A0 (en) 1977-03-31
IL51267A (en) 1979-12-30
ES455404A1 (es) 1978-05-01
SE441359B (sv) 1985-09-30
DK146940C (da) 1984-07-30
IE44759L (en) 1977-07-31
NL7700892A (nl) 1977-08-02
CH638529A5 (de) 1983-09-30
KE3303A (en) 1983-08-05
AU515736B2 (en) 1981-04-30
AU2177077A (en) 1978-08-03
RO69712A (fr) 1980-07-15
FI63581B (fi) 1983-03-31
SE7700946L (sv) 1977-08-01
DK38577A (da) 1977-08-01
JPS613349B2 (es) 1986-01-31
YU10777A (en) 1982-06-30
PT66071B (en) 1978-06-23
IE44759B1 (en) 1982-03-24
US4428958A (en) 1984-01-31
AR216555A1 (es) 1979-12-28
FI770295A (es) 1977-08-01
CS196341B2 (en) 1980-03-31

Similar Documents

Publication Publication Date Title
MX6174E (es) Procedimiento para la preparacion de(4-trifluorometil)-anilida de acido 5-metil-isoxazol-4-carboxilico
ES494590A0 (es) Procedimiento para la preparacion de derivados de acidos b- carbolin-3-carboxilicos
ES494431A0 (es) Un procedimiento para la preparacion de acido clavulanico
TR19755A (tr) Tereftalik asidin hazirlanmasina mahsus usul
MX5477E (es) Procedimiento para la preparacion de derivados de acido pseudomonico
MX5149E (es) Procedimiento mejorado para la preparacion de derivados de acido cicloalquilidenmetilfenilacetico
AR221428A1 (es) Procedimiento para la preparacion de derivados de pirrolidinil-y de pirrolidinilmetil-benzamidas
MX4950E (es) Procedimiento para la preparacion de tioesteres de acido clavulanico
MX5006E (es) Procedimiento para la preparacion de acido ciclohexancarboxilico
MX5098E (es) Procedimiento para la preparacion de esteres de acido ciclopropancarboxilicos
MX5594E (es) Procedimiento mejorado para la preparacion de derivados de n-trifluoroacetil-n-fosfonometilglicinatos
MX4601E (es) Procedimiento para la preparacion de esteres bencilicos de acido 2-isoprofil-4-fenil-3-butenico
ES490729A0 (es) Procedimiento para la preparacion de nuevas imidas de acido ciclobutandicarboxilico
AR225421A1 (es) Procedimiento mejorado para la preparacion de esteres 1-oxido de 3-exometilencefam
MX5206E (es) Procedimiento para la preparacion de fenoxi-alfa-vinil-bencil-esteres de acido ciclopropancarboxilico
AR218294A1 (es) Procedimiento para la preparacion de derivados de acido oleanoico
ES491601A0 (es) Procedimiento para la preparacion de derivados de acido n-acil-amino
MX5207E (es) Procedimiento para la preparacion de 3-fenoxi-alfa-vinilbencilesteres de acido vinilciclopropancarboxilico
ES494594A0 (es) Procedimiento para la preparacion de derivados de acidos al-canocarboxilicos
ES490959A0 (es) Procedimiento para la preparacion de derivados de acidos pi-rrolidinilsulfamoilbenzoicos sustituidos
AR217802A1 (es) Procedimiento para la preparacion de derivados de acido 3-oxo-d-homoandrost-4-eno-17a beta-carboxilico
MX5593E (es) Procedimiento mejorado para la preparacion de derivados de ester de n-trifluoroacetil-n-fosfonometilglicina
MX4846E (es) Procedimiento para la preparacion de eteres de acido clavulanico
MX4348E (es) Procedimiento para la preparacion de analogos de cefalosporina
ES497743A0 (es) Procedimiento para la preparacion de esteres alquinilicos deacido ciclopropancarboxilico